Displaying drugs 526 - 550 of 12870 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Bixalomer | Not Annotated |  | Bixalomer is under investigation in clinical trial NCT01115985 (A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers). | Amines |
| IDM-1 | Not Available |  | Ovarian cancer | Not Available |
| Pentastarch | Not Available |  | A plasma volume expander used as an adjunct in the management of shock due to hemorrhage, surgery, sepsis, burns or other trauma. | Plasma Substitutes / Starch |
| IDM-2 | Not Available |  | Investigated for use/treatment in bladder cancer. | Not Available |
| Rauwolfia serpentina root | Not Available |  | Rauwolfia alkaloids are indicated in the treatment of hypertension . Rauwolfia alkaloids have been used for relief of symptoms in agitated psychotic states such as schizophrenia; however, use as antipsychotics... | Secologanin Tryptamine Alkaloids |
| Aluminum sesquichlorohydrate | Not Annotated |  | An antiperspirant used to reduce sweating. | Alkalies / Aluminium Compounds / Anions / Chlorine Compounds / Electrolytes / Hydroxides / Ions / Metal cations / Metal divalent cations |
| EQ101 | Not Annotated |  | Not Annotated | Not Annotated |
| CEB-01 | Not Annotated |  | CEB-01 is a biocompatible polymeric PLGA nanofiber membrane containing the active substance 7-ethyl-10-hydroxycamptothecin | Not Annotated |
| CAM-2029 | Not Available |  | Investigated for use/treatment in acromegaly and cancer/tumors (unspecified). | Not Available |
| Dociparstat sodium | Not Available |  | Not Available | Experimental Unapproved Treatments for COVID-19 |
| KAI-1455 | Not Available |  | Investigated for use/treatment in ischemic reperfusion injury. | Not Available |
| Hydroxyethyl ethylcellulose | Not Annotated |  | Hydroxyethyl ethylcellulose modulates bacterial binding to salivary pellicle; moderately effective in preventing plaque formation. | Biopolymers / Carbohydrates / Compounds used in a research, industrial, or household setting / Glucans / Macromolecular Substances / Polymers / Polysaccharides |
| BBP-711 | Not Annotated |  | BBP-711 is a glycolate oxidase inhibitor. | Not Annotated |
| SGS518 | Not Available |  | Investigated for use/treatment in neurologic disorders and schizophrenia and schizoaffective disorders. | Not Available |
| Lanolin | Not Available |  | An ingredient used in skin care products to relieve irritation. | Cosmetics / Waxes |
| Dipropylene glycol | Not Annotated |  | Not Annotated | Not Annotated |
| IK-930 | Not Annotated |  | IK-930 is an oral, paralog-selective TEAD inhibitor. | Not Annotated |
| GSK159797 | Not Available |  | Investigated for use/treatment in asthma and chronic obstructive pulmonary disease (COPD). | Not Available |
| 99mTc-glucarate | Not Available |  | Investigated for use/treatment in myocardial infarction. | Not Available |
| Tilmanocept | Not Annotated |  | Tilmanocept is under investigation in clinical trial NCT03241446 (Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis... | Not Annotated |
| PSN357 | Not Available |  | Investigated for use/treatment in diabetes mellitus type 2. | Not Available |
| Polyestradiol phosphate | Not Annotated |  | Polymeric phosphoric acid ester of estradiol. | Estrogens |
| Methoxy PEG-12 retinamide | Not Annotated |  | Not Annotated | Pegylated agents |
| EA-2353 | Not Annotated |  | EA-2353 is a small molecule inhibitor of kinase mediators of the Wnt pathway. | Not Annotated |
| PTI-801 | Not Available |  | Investigated for use/treatment in addictions, osteoarthritis, and pain (acute or chronic). | Not Available |
Displaying drugs 526 - 550 of 12870 in total